Sellas Life Sciences Group Inc (SLS)
Fair Value-33.9% Downside
Overvalued
Analyst312.4% Upside
Market Cap1.591 B
P/E—
Yield0.0%
HealthGood
NASDAQ
Tenax Therapeutics Inc (TENX)
Fair Value35.8% Upside
Undervalued
Analyst490.5% Upside
Market Cap93.37 M
P/E—
Yield0.0%
HealthWeak
NASDAQ
Vanda Pharmaceuticals Inc (VNDA)
Fair Value38.9% Upside
Undervalued
Analyst220.3% Upside
Market Cap217.1 M
P/E—
Yield0.0%
HealthWeak
NASDAQ
Vericel Corp Ord (VCEL)
Fair Value-5.9% Downside
Fair
Analyst15.3% Upside
Market Cap2.643 B
P/E109.5x
Yield0.0%
HealthGreat
NASDAQ
Vertex Pharmaceuticals Inc (VRTX)
Fair Value-8.6% Downside
Fair
Analyst6.7% Upside
Market Cap137.5 B
P/E34.6x
Yield0.0%
HealthGood
NASDAQ
Agios Pharm (AGIO)
Fair Value38.3% Upside
Undervalued
Analyst62.3% Upside
Market Cap1.682 B
P/E—
Yield0.0%
HealthFair
NASDAQ
Akari Therapeutics PLC (AKTX)
Fair Value18.9% Upside
Undervalued
Analyst229.0% Upside
Market Cap17.71 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Akebia Ther (AKBA)
Fair Value89.7% Upside
Bargain
Analyst819.4% Upside
Market Cap117.9 M
P/E—
Yield0.0%
HealthGood
NASDAQ
Aldeyra The (ALDX)
Fair Value28.8% Upside
Undervalued
Analyst971.4% Upside
Market Cap37.65 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Amarin Corporation PLC (AMRN)
Fair Value7.9% Upside
Fair
Analyst12.3% Upside
Market Cap243.9 M
P/E—
Yield0.0%
HealthGood
NASDAQ
Anavex Life Sciences Corp (AVXL)
Fair Value38.7% Upside
Undervalued
Market Cap102.9 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Anixa Biosciences Inc (ANIX)
Fair Value-30.0% Downside
Overvalued
Analyst219.0% Upside
Market Cap105.3 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Arbutus Biopharma Corp (ABUS)
Fair Value18.1% Upside
Undervalued
Analyst48.4% Upside
Market Cap723.1 M
P/E4.7x
Yield0.0%
HealthGreat
NASDAQ
Featured in
Financially Strong Value
High-Growth Small-Cap Stocks
Arcturus Therapeutics Holdings Inc (ARCT)
Fair Value29.0% Upside
Undervalued
Analyst154.3% Upside
Market Cap266 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Ardelyx Inc (ARDX)
Fair Value27.8% Upside
Undervalued
Analyst328.1% Upside
Market Cap747.8 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Atossa Therapeutics Inc (ATOS)
Fair Value26.6% Upside
Undervalued
Analyst840.6% Upside
Market Cap20.158 M
P/E—
Yield0.0%
HealthWeak
NASDAQ
Aurinia Pharmaceuticals Inc (AUPH)
Fair Value27.5% Upside
Undervalued
Analyst12.8% Upside
Market Cap2.172 B
P/E6.9x
Yield0.0%
HealthExcellent
NASDAQ
Featured in
Financially Strong Value
Avita Medical Ltd (RCEL)
Fair Value-37.0% Downside
Overvalued
Analyst-14.6% Downside
Market Cap484.9 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Benitec Biopharma Ltd ADR (BNTC)
Fair Value-12.0% Downside
Fair
Analyst169.5% Upside
Market Cap301.4 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Capricor Therapeutics Inc (CAPR)
Fair Value-1.9% Downside
Fair
Analyst214.0% Upside
Market Cap501.2 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Cardiff Oncology Inc (CRDF)
Fair Value35.6% Upside
Undervalued
Analyst732.2% Upside
Market Cap58.759 M
P/E—
Yield0.0%
HealthWeak
NASDAQ
Featured in
Bullish Trend Stocks
Caredx Inc (CDNA)
Fair Value-25.0% Downside
Overvalued
Analyst22.5% Upside
Market Cap4.01 B
P/E31.2x
Yield0.0%
HealthGreat
NASDAQ
Featured in
High-Momentum Stocks
Bullish Trend Stocks
Cellectar Biosciences Inc (CLRB)
Fair Value48.9% Upside
Undervalued
Analyst900.0% Upside
Market Cap10.917 M
P/E—
Yield0.0%
HealthFair
NASDAQ
CervoMed Inc (CRVO)
Fair Value37.4% Upside
Undervalued
Analyst934.5% Upside
Market Cap22.225 M
P/E—
Yield0.0%
HealthWeak
NASDAQ
Clinuvel Pharmaceuticals Ltd ADR (CUVL)
Fair Value45.7% Upside
Undervalued
Market Cap270.7 M
P/E11.3x
Yield0.6%
HealthGreat
NASDAQ
Crescent Biopharma Inc (CBIO)
Fair Value-8.9% Downside
Fair
Analyst143.4% Upside
Market Cap552.3 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Dyadic International Inc (DYAI)
Fair Value46.7% Upside
Undervalued
Market Cap12.415 M
P/E—
Yield0.0%
HealthWeak
NASDAQ
Edesa Biotech Inc (EDSA)
Fair Value20.0% Upside
Undervalued
Analyst666.8% Upside
Market Cap28.915 M
P/E—
Yield0.0%
HealthWeak
NASDAQ
Eledon Pharmaceuticals Inc (ELDN)
Fair Value-8.1% Downside
Fair
Analyst265.9% Upside
Market Cap199.7 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Enanta Pharmaceuticals Inc (ENTA)
Fair Value-6.9% Downside
Fair
Analyst116.6% Upside
Market Cap293.7 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Enlivex Therapeutics Ltd (ENLV)
Fair Value48.2% Upside
Undervalued
Market Cap1.605 M
P/E—
Yield0.0%
HealthGood
NASDAQ
Ernexa Therapeutics Inc (ERNA)
Fair Value40.9% Upside
Undervalued
Market Cap2.987 M
P/E—
Yield0.0%
HealthWeak
NASDAQ
Evogene Ltd (EVGN)
Fair Value27.2% Upside
Undervalued
Analyst551.5% Upside
Market Cap4.733 M
P/E—
Yield0.0%
HealthWeak
NASDAQ
Exelixis Inc (EXEL)
Fair Value1.7% Upside
Fair
Analyst-10.7% Downside
Market Cap16.751 B
P/E18.9x
Yield0.0%
HealthExcellent
NASDAQ
Fate Therapeutics Inc (FATE)
Fair Value9.5% Upside
Fair
Analyst210.5% Upside
Market Cap222.3 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Galectin Therapeutics Inc (GALT)
Fair Value-40.3% Downside
Overvalued
Analyst268.5% Upside
Market Cap300.5 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Genmab AS (GMAB)
Fair Value11.4% Upside
Fair
Analyst23.2% Upside
Market Cap32.603 B
P/E41.4x
Yield0.0%
HealthGreat
NASDAQ
GeoVax Labs Inc (GOVX)
Fair Value35.4% Upside
Undervalued
Market Cap1.439 M
P/E—
Yield0.0%
HealthWeak
NASDAQ
GT Biopharma Inc (GTBP)
Fair Value15.3% Upside
Fair
Market Cap8.12 M
P/E—
Yield0.0%
HealthWeak
NASDAQ
Heron Therapeuti (HRTX)
Fair Value17.6% Upside
Fair
Analyst614.3% Upside
Market Cap52.817 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Ibio Inc (IBIO)
Fair Value46.1% Upside
Undervalued
Analyst679.2% Upside
Market Cap46.948 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Immunic Inc (IMUX)
Fair Value54.1% Upside
Bargain
Analyst488.7% Upside
Market Cap100.6 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Immutep Ltd ADR (IMMP)
Fair Value91.7% Upside
Bargain
Market Cap21.463 M
P/E—
Yield0.0%
HealthWeak
NASDAQ
Inovio Pharmaceuticals Inc (INO)
Fair Value-46.5% Downside
Overvalued
Analyst267.8% Upside
Market Cap149.9 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Iovance Biotherapeutics Inc (IOVA)
Fair Value24.0% Upside
Undervalued
Analyst84.8% Upside
Market Cap3.49 B
P/E—
Yield0.0%
HealthGood
NASDAQ
Featured in
High-Momentum Stocks
Bullish Trend Stocks
Kamada Ltd (KMDA)
Fair Value41.8% Upside
Undervalued
Analyst96.5% Upside
Market Cap388.4 M
P/E17.5x
Yield2.3%
HealthGreat
NASDAQ
Larimar Therapeutics Inc (LRMR)
Fair Value55.3% Upside
Bargain
Analyst520.7% Upside
Market Cap241.6 M
P/E—
Yield0.0%
HealthWeak
NASDAQ